向更好的结果导航急性髓性白血病:对于无法接受密集化疗的患者的治疗途径和挑战
Raffaele Palmieri1, Anna Candoni2, Francesco Di Raimondo3
1Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Viale Oxford 81, Rome, Italy.
本综述讨论了老年人不适合进行密集化疗的急性髓性白血病 (AML) 的管理. 它强调了选择最佳的低强度治疗的挑战,并建议了更好的患者评估和护理的策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 内部医学 内部医学
背景情况:
- 急性髓性白血病 (AML) 是一种侵袭性癌症,主要影响老年人.
- 不适合接受密集化疗的患者的预后不好.
- 新的低强度疗法正在为这个患者群体出现.
研究的目的:
- 审查目前对AML患者不适合进行密集化疗的治疗策略.
- 突出选择适合这一群体的治疗方法的挑战.
- 建议改善患者评估和治疗决策.
主要方法:
- 对当前反洗钱管理指南和研究的文献综述.
- 对评估患者适应化疗的现有工具的分析.
- 讨论针对AML的新型低强度治疗选择.
主要成果:
- 目前评估患者健康状况的方法可能不足以适应新的治疗方案.
- 在最佳的患者评估方案上缺乏共识.
- 选择不适合AML患者的最佳治疗方法越来越复杂.
结论:
- 准确的患者评估对于指导AML治疗决策至关重要.
- 需要改进的策略来管理AML患者不适合进行密集化疗.
- 为了在新疗法时代获得最佳护理,需要进一步的研究和共识发展.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Treatment Resistant Cancers
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
